President Trump received a high dose of an experimental antibody cocktail from Regeneron as part of his Covid-19 treatment. Now the drugmaker’s stock is up sharply — and questions are swirling about the president’s ties to Regeneron’s billionaire CEO.
Trump has ties to drug maker Regeneron — and now its stock is surging
